Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients.
Diagnosis of polycystic ovary syndrome (PCOS), at present very common in women of reproductive age, is implicated with potential long-term metabolic consequences that are difficult to be investigated due to the heterogeneity in the manifestation of the syndrome. The present study constitutes an effort to explore the graduated metabolic impact of the different PCOS phenotypic groups through the levels of adiponectin, an adipose-derived hormone, in 100 normal weight, normoinsulinemic patients with PCOS.
Karkanaki
Artemis
A
Division of Endocrinology and Human Reproduction, Second Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Thessaloniki, Greece. kartemis2004@hotmail.com
Piouka
Athanasia
A
Katsikis
Ilias
I
Farmakiotis
Dimitrios
D
Macut
Djuro
D
Panidis
Dimitrios
D
D052242:Adiponectin / Q000097:blood; D015415:Biomarkers / Q000097:blood*; D001835:Body Weight; D005260:Female; D018740:Genetic Heterogeneity; D006801:Humans; D007328:Insulin / Q000097:blood*; D010641:Phenotype; D011085:Polycystic Ovary Syndrome / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism*
C499918:ADIPOQ protein, human; D052242:Adiponectin; D015415:Biomarkers; D007328:Insulin